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the main mechanism implicated in the spread of antibiotic resistance genes (ARG). This study is 
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conducting a microcosm experiment that uses Emulsion, Paired-Isolation and Concatenation PCR 
(epicPCR) to monitor the spread of ARGs between species. 
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Sequence-based prediction method was applied to find regions that tolerate insertions inside the 
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useful, but it does not guarantee that the protein function is maintained. 
Avainsanat — Nyckelord — Keywords  
Antibiotic resistance, antibiotic susceptibility testing, protein engineering, sequence-based prediction 
Säilytyspaikka — Förvaringsställe — Where deposited   
https://ethesis.helsinki.fi/en/ 
Muita tietoja — Övriga uppgifter — Further information  
Supervisors: Veera Partanen and Marko Virta 
HELSINGIN YLIOPISTO — HELSINGFORS UNIVERSITET — UNIVERSITY OF HELSINKI 
Tiedekunta — Fakultet — Faculty  
Maatalous-metsätieteellinen tiedekunta 
Masters´s Programme  
Mikrobiologian ja mikrobibiotekniikan 
maisteriohjelma 
Tekijä — Författare — Author  
Iina Jormanainen 
Työn nimi — Arbetets titel — Title  
Antibioottiresistenssigeenien muokkaaminen ja proteiinien toiminnan testaus 
antibioottiherkkyysmäärityksellä 
Työn laji — Arbetets art — Level  
Maisterintutkielma 
Aika — Datum — Month and year  
Marraskuu 2021 
  
Tiivistelmä — Referat — Abstract 
Antibioottiresistenssin leviäminen bakteereissa on maailmanlaajuinen ongelma. Horisontaalinen 
geeninsiirto on tärkein antibioottiresistenssigeenien leviämiseen liittyvä mekanismi. Tämä tutkimus 
liittyy väitöskirjatyöhön, jossa tutkitaan horisontaalista geeninsiirtoa jäteveden mikrobiyhteisössä 
mikrokosmoskokeen avulla. Kokeessa hyödynnetään epicPCR-menetelmää (Emulsion, Paired-
Isolation and Concatenation PCR) antibioottiresistenssigeenien leviämisen seurannassa lajien välillä.  
Tämän tutkimuksen tarkoituksena oli lisätä synteettiset epicPCR-alukkeiden sitoutumiskohdat usean 
eri antibioottiresistenssigeenin sisään ja testata geenien koodaamien proteiinien toiminta. 
Tavoitteena oli ylläpitää riittävä proteiinin toiminta eli antibioottiresistenssi muokkauksista 
huolimatta, mikä mahdollistaa muokattujen antibioottiresistenssigeenien jatkokäytön 
mikrokosmoskokeessa. Muokattaviksi valitut geenit tässä työssä olivat dfrB2, ermB, ermC, sul1 ja 
sul2. 
Sekvenssipohjaista ennustamismenetelmää sovellettiin insertion sallivien paikkojen etsimisessä 
antibioottiresistenssigeenien koodaamien proteiinien sisältä. Muokatut geenit siirrettiin vektorissa 
pUC19 Escherichia coli DH5α -kantaan, jota käytettiin isäntänä antibioottiherkkyystestauksessa. 
Kantojen antibioottiherkkyyden testaamiseen ja proteiinien toiminnan tarkistamiseen käytettiin 
gradienttiliuskamenetelmää. 
Kuusi tässä tutkimuksessa muokatuista antibioottiresistenssigeeneistä tuotti toiminnallisen, 
antibioottiresistenssin antavan proteiinin, kun taas kolme muokatuista geeneistä eivät. Kaksi neljästä 
proteiinista, joille oli tehty insertio sen sallivaksi ennustettuun paikkaan, säilytti toiminnallisuutensa. 
Tässä tutkimuksessa suunniteltua kuutta toiminnallista, antibioottiresistenssin tuottavaa geeniä 
voidaan käyttää epicPCR:ää hyödyntävissä jatkotutkimuksissa. Tämän tutkimuksen tulosten 
perusteella sekvenssipohjainen ennustamismenetelmä sallivien paikkojen löytämiseksi vaikuttaa 
käyttökelpoiselta, mutta se ei kuitenkaan takaa proteiinin toiminnallisuuden säilymistä. 
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Antibiotic resistance of bacteria is one of the biggest problems the world is facing today (World 
Health Organization, 2020). Antibiotic resistance has existed naturally before human antibiotic use 
(Hughes & Datta, 1983) and even now it is present in natural environments (Allen et al., 2010). Many 
human, animal and natural environments are involved in the emergence, acquisition and spread of 
antibiotic resistance (Hernando-Amado et al., 2019). Irresponsible use of antibiotics in agriculture 
and human healthcare has caused the spreading of antibiotic resistance to increase. Other factors 
contributing to the spread are for example the co-selection of antibiotic resistance genes with heavy 
metals and biocides and the effects of global warming such as the increase of space where bacteria, 
humans, animals, and vector species can interact. The increasing spread of antibiotic resistance 
endangers both human and animal health as well as food security (World Health Organization, 
2020). The spread of antibiotic resistance in human pathogens has led to antibiotics losing their 
effectiveness, making injuries and common infections such as pneumonia, tuberculosis, 
salmonellosis, and gonorrhea harder to treat. As a result, medical costs become higher, and 
mortality increases.  
Clinical and agricultural use of antibiotics leads to the presence of antibiotics in soil and aquatic 
environments (Allen et al., 2010). One reason for this is that the antibiotics consumed by humans 
or animals are largely excreted from the body (Thiele-Bruhn, 2003). The persistence of antibiotics in 
the environment creates a pressure that selects for antibiotic resistance in bacteria (Allen et al., 
2010; Hiltunen et al., 2017). Big part of the problem is that many of the known antibiotic resistance 
genes (ARGs) are found in mobile genetic elements such as plasmids and transposons and therefore 
ARGs can effectively spread between bacterial strains and species. A main mechanism for the 
spreading of antibiotic resistance is horizontal gene transfer, the exchange of genetic material 
between bacterial cells that allows bacteria to acquire new genes from the environment. 
Wastewater treatment plants (WWTPs) are possible hotspots for the spread of ARGs and bacteria 
(Rizzo et al., 2013). Because bacteria from different environmental sources enter the WWTPs and 
are there in close contact, it is possible that ARGs are transferred from environmental bacteria to a 
pathogen, or vice versa. Previous studies suggest that ARGs are transferred between species in 
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WWTPs, though the treatment process mainly succeeds in decreasing the host range of ARGs 
(Hultman et al., 2018). In WWTPs bacteria and antibiotics at sub-inhibitory concentrations are 
simultaneously present, which creates a suitable environment for HGT and thus for the spreading 
of antibiotic resistance (Rizzo et al., 2013). However, the factors and mechanisms that are 
responsible for maintaining and selecting antibiotic resistance in wastewater are not yet well 
understood.  
This Master’s thesis is related to a Doctoral thesis project of Veera Partanen, which aims to monitor 
the transfer of ARGs in wastewater microbial communities in experimental conditions. To follow the 
spread of ARGs in microbial communities a method called Emulsion, Paired-Isolation and 
Concatenation Polymerase Chain Reaction (epicPCR) (Spencer et al., 2016) will be applied. The 
method reveals the current hosts of the ARG by linking it with 16S rRNA gene on single cell level. 
For Doctoral thesis project, epicPCR primer binding sites need to be added to several different ARGs 
and these primer binding sites need to be the same. Having the same epicPCR primer binding sites 
in different ARGs allows the amplification of several ARGs in one reaction. If the primer binding sites 
were specific to each ARG, every gene would have to be individually analyzed, making the epicPCR 
more laborious. ARGs with primer binding sites for epicPCR will also be tagged with a unique 
barcode sequence, which tells the donor of the ARG, while epicPCR linking reveals the current host.  
Adding amino acids in the middle of a protein while retaining protein function requires the 
identification of a permissive site. A permissive site is a place in a protein which tolerates relatively 
large insertions without a loss of protein function (Oesterle et al., 2017). One approach for 
permissive site identification is to use a pentapeptide scanning mutagenesis, which is a technique 
that utilizes transposons (for example in Goodale et al. 2020). Another approach for finding 
permissive sites is to use sequence-based prediction (Oesterle et al., 2017). This relatively new 
method relies on the hypothesis that protein’s amino acid sequence information is enough to reveal 
stretches that tolerate insertions (Burg et al., 2016; Oesterle et al., 2017). Regions that have low 
conservation and are variable in length between homologs are thought to be less likely relevant for 
the protein function. Length variable regions contain insertions or deletion (indels) and indels often 
occur in a loop structure on the surface of a protein (Chang & Benner, 2004). Sequence-based 
prediction of permissive sites was chosen for this study because the novel method claimed to be 
less laborious than the pentapeptide scanning mutagenesis. Also, the pentapeptide scanning 
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mutagenesis leaves a transposase recognition site flanking the inserted sequence, which may lead 
to the loss of protein function (Billerbeck et al., 2013). 
EpicPCR is a relatively new method and is not known to have been used to amplify long sequence 
fragments. Successful amplification with epicPCR has been reported when a sequence to be linked 
to 16s rRNA were less than 300 nucleotides in length (Cairns et al., 2018; Hultman et al. 2018; 
unpublished data). Therefore, it is necessary to determine whether the binding site of the epicPCR 
primer can be placed in the middle of the gene of interest, making the length of the sequence to be 
amplified and linked more advantageous for epicPCR. In addition, it is necessary to find out whether 
the primer binding sites can be placed inside the start and stop codons of a gene. This would allow 
primer binding sites to be selected with the ARG even if the gene changes its genetic environment. 
The aim of this study was to introduce synthetic primer binding sites and a barcode sequence inside 
various ARGs and to test the function of the encoded proteins. The function of the protein, i.e., the 
antibiotic resistance, was to be maintained despite the modifications. The required features for the 
ARGs to be designed were that they needed be amplifiable by epicPCR and selectable by the 
corresponding antibiotic in experimental conditions. To ensure successful amplification by epicPCR, 
addition of the epicPCR primer binding site sequence to the middle of a gene in a region predicted 
as permissive was explored for some the genes selected for this study. However, epicPCR itself was 
not performed in this study and thus the epicPCR amplifiability of the genes was not tested. The 
function of the proteins was verified with antibiotic susceptibility testing where the transformant 
strain carrying the modified genes were compared to strains carrying wild type genes. 
MATERIALS AND METHODS 
Genes and proteins 
The ARGs for this study were searched from a set of ARGs located on plasmids available for the 
Molecular Environmental Biosciences research group, in which this study was conducted (Table 1). 
The requirement for these thirteen genes was that the gene needed to be beneficial to the host only 
and not to other microbes in the environment. Of these thirteen ARGs, six genes, dfrB2, ermB, ermC, 
ermF, sul1 and sul2, were selected for this study (Table 2). The genes were selected because a 3D 
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model of the structure of the protein encoded by the gene is published in a public database. 3D 
models were searched against UniProtKB/SwissProt database (Boutet et al. 2007) and Protein Data 
Bank (Berman et al., 2000) based on amino acid sequence using NCBI BLASTp (Altschul et al. 1990) 
with default settings.  
Table 1. A list of antibiotic resistance genes located on plasmids. The GenBank accession numbers 
refer to the plasmids on which the gene is located, except for ermF gene where the accession 
number refers to the gene only. Genes of the same name are marked with different numbers in the 
superscript. 
Gene Plasmid Accession number 
dfrA pKJK5 AM261282.1 
dfrB2 R388 NC_028464.1 
ermB pAMbeta1 NC_013514.1 
ermC pE194 NC_005908.1 
ermF pVA831 (pBF4)  M14730.1 
floR pAB5S9 NC_009476.1 
sul1 pKJK5 AM261282.1 
sul21 pAB5S9 NC_009476.1 
sul22 RSF1010  M28829.1 
tetA1 pKJK5 AM261282.1 
tetA2 RP4 X75761.1 
tetC pRAS3.3 NZ_KJ909291.1 
tetY pAB5S9 NC_009476.1 
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Table 2. Data of antibiotic resistance genes used in this study. An antibiotic against which the gene 
confers resistance, size of the gene in base pairs (bp) and proteins encoded by antibiotic resistance 
genes as well as their UniProtKB accession numbers. 
Gene Resistance against Size (bp) Protein Accession number 



















798  23S rRNA adenine(2058)-
N(6))-methyltransferase 
P10337 
sul1 sulfonamide 839  Dihydropteroate synthase 
type 1 
P0C002 
sul21 sulfonamide 815  Dihydropteroate synthase 
type 2 
P0AC11 
Permissive stretch search  
In this work, a previously described method for finding a permissive stretch based on amino acid 
sequence was applied (Oesterle et al. 2017). Proteins of interest were searched for permissive 
stretches by aligning the amino acid sequence of each protein with the amino acid sequence of 4-6 
homologous proteins. The homologs were retrieved from Universal Protein Resource 
Knowledgebase (Bateman et al., 2021) using Domain Enhanced Lookup Time Accelerated BLAST 
(DELTA-BLAST) (Boratyn et al. 2012). Criteria for homologs selected for multiple sequence alignment 
(MSA) were similarity of 30% to 70% in amino acid sequence and a query coverage greater than 
80%.  
The multiple sequence alignment was performed using the online version of Clustal Omega program 
with default parameters (November 17th  ̶18th, 2020) (Sievers et al., 2011). From MSA data, gaps 
were searched to identify a region permissive to insertion. A possible permissive stretch was 
identified as a gap in the MSA along with residues flanking the gap. In this work, the stretches were 
searched for within the region of the first 100 amino acids so that the sequence to be amplified in 
epicPCR would be less than 300 base pairs. The location of the permissive stretch was further 
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evaluated by examining the 3D structural data of the protein. The aim was to find stretches located 
in a flexible loop region.  
For protein encoded by ermB, DELTA-BLAST yielded homologs, but the homologs did not reveal gaps 
in the MSA. Therefore, for this protein the homologs were retrieved using protein-protein BLAST 
with default parameters as they revealed gaps in the MSA. For protein encoded by dfrB2 permissive 
stretch search was not done because inserting the epicPCR primer binding site in the middle of the 
gene was not necessary. DfrB2 is relatively small (236 bp) and hence the epicPCR product would be 
within the desired length (less than 300 bp) when the whole gene is amplified. 
Modified genes 
Three types of genes were designed in this study (Fig. 1.). Type A gene included an ARG sequence, 
forward primer binding site for epicPCR after the start codon, a barcode sequence following the 
forward primer binding site for epicPCR and a reverse forward primer binding site for epicPCR at the 
end of the gene before stop codon. In type B gene, the reverse forward primer binding site for 
epicPCR was placed in the middle of the protein in a region identified as permissive. For type C gene 
no modifications were made. Type C is therefore also referred as a wild type gene. For each gene, 
Shine-Dalgarno sequence (AGGAGG) was added upstream of the start codon to ensure ribosome 
binding, which allows gene expression in the host plasmid. Five bases (CAGCT) were added between 
Shine-Dalgarno sequence and start codon. These five bases were chosen since the same set 





Figure 1. Illustration of designed inserts. Types of modifications: (A) epicPCR forward primer 
binding site and barcode added after the start codon, epicPCR reverse primer binding site added to 
the end of the gene before stop codon, (B) epicPCR forward primer binding site and barcode added 
after the start codon, epicPCR reverse primer binding site added to the middle of the gene (C) wild 
type gene; no epicPCR primer binding sites added. 
The adding of epicPCR primer binding sites and barcode (Table 3) to the ARG sequence required 
addition of extra bases to maintain correct reading frame for the gene. The bases were selected so 
that the amino acids encoded by the codons would be as small and harmless to the protein structure 
as possible. Amino acids known to have a key role in protein structure such as cysteine (Matsumura 
et al., 1989) and proline (MacArthur & Thornton, 1991) were avoided, as well as other amino acids 
with long side chains or side chains containing sulfur. As the insertions in predicted permissive 
stretches for type B genes were to be done on surface-exposed loops, the amino acids encoded by 
epicPCR primer binding sites were confirmed to be mainly hydrophilic amino acids, which are prone 
to exist on protein surfaces.  
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Table 3. Nucleotide and amino acid sequences of insertions to antibiotic resistance genes. Forward 
epicPCR primer binding site is in blue, reverse epicPCR primer binding site in green, barcode 
sequence in pink and additional bases in yellow. 
 Nucleotide sequence Amino acid sequence 
EpicPCR forward primer 
binding site and barcode 
GGTCGTGAGCACCTAGGGTCTCATGCCATT GREHLGSHAI 
EpicPCR reverse primer 
binding site  
GGGCAGAGCCTCAGAACACTT GQSLRTL 
For the proteins encoded by genes ermB, ermC, sul1 and sul2 all three gene types were explored. 
ErmF was excluded from further experiments because of its difficulties to be expressed in 
Escherichia coli (Rasmussen et al. 1986), which was the chosen host for both cloning and expression. 
In type B, epicPCR reverse primer binding site was inserted to a site identified as permissive. The 
insertion was done either by inserting the new sequence without deleting residues or by deleting a 
residue or more in the process. Amino acid sequences highlighting the permissive stretches and 
insertions are shown in Table 4. The naming of the genes in this study is as following: the letter a, b 
or c following the original gene name indicates the type of modification done to the gene (Fig. 3). 
The name of an amino acid residue indicates the insertion site in the protein encoded by the gene. 
For example, ermB_b_91N is ermB gene with type B modification where epicPCR reverse primer 
binding site is added immediately after residue 91N.  
The designed inserts were placed in a plasmid pUC19 (Yanisch-Perron et al., 1985) at HindIII/BamHI 
cloning site. The plasmids containing the designed inserts were ordered from Genscript Biotech, 
Netherlands and they were delivered in lyophilized form. The lyophilized plasmids were dissolved 
into 20 µl of sterile water according to the manufacturer’s instructions to prepare them for 
transformation. The plasmid DNA concentrations were determined using Qubit 4 Fluorometer 





Table 4. Overview of insertions in predicted permissive stretches. The added sequence to the target protein is the amino acid sequence 
corresponding to the epicPCR reverse primer binding site (Table 3). If a base/residue was deleted from the original sequence during insertion, it 





sequence of the 
permissive 
stretch 















72L CTTGTTGAT CTTGGGCAGAGCCTCAGAACACTTGAT LVD LGQSLRTLD 
Dihydropteroate synthase 
type 1 (sul1) 
72L CTGTCC CTGGGGCAGAGCCTCAGAACACTTTCC LS LGQSLRTLS 
Dihydropteroate synthase 
type 2 (sul2) 
75L  CTCAAGGCA CTCGGGCAGAGCCTCAGAACACTTGCA LKA LGQSLRTLA 
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Bacterial strains and growth conditions 
Escherichia coli DH5α strain was used as a cloning and expression host. The bacteria were grown on 
Luria-Bertani (LB) agar or LB broth medium at +37°C, the latter with shaking (220 rpm). For 
transformants with pUC19 plasmid 100 µg/ml of ampicillin was added for selection. Ampicillin was 
the selective agent on the plates as pUC19 plasmid contains an ampicillin resistance gene.  
Preparation of competent cells 
One colony from an overnight pure culture plate of E. coli DH5α was inoculated into a 50 ml LB broth 
flask. The flask was incubated overnight at +37 °C with shaking and on the following day 25 ml of 
the culture was inoculated into 500 ml of LB broth. The cells were grown with vigorous shaking at 
+37 °C to an OD580 of 0.4. Immediately after this the culture flask was chilled on ice approximately 
for 25 min. The cooled cell culture was transferred to sterile centrifuge bottle and 275 ml of LB broth 
was added to reach a final volume of 800 ml. The cells were centrifuged at 1000 x g for 15 min at 4 
°C. The supernatant was removed, and the cells were resuspended in 800 ml of ice-cold sterile water 
and centrifuged at 1000 x g for 20 min at 4 °C. The pelleted cells were resuspended in 250 ml of ice-
cold 10 % (v/v) glycerol and centrifuged as above. Again, the supernatant was removed, and the 
pelleted cells were resuspended in 10 ml of 10 % (v/v) glycerol and centrifuged as above. The final 
suspension of cells was done in 800 µl of ice-cold 10 % (v/v) glycerol. The OD600 value of the 1:100 
suspension was 0.375. The suspension was divided in 40 µl aliquots and the tubes were stored at -
80 °C until use. 
Transformation 
The transformation was carried out by electroporation. The electroporation was performed 
according to the New England Biolabs (2019) protocol with minor modifications. Plasmid pUC19 was 
used as a positive and PCR grade water as negative electroporation control. 1 µl of plasmid DNA 
solution (10 pg/ µl) or PCR grade water was mixed with 40 µl of electrocompetent cells. The cell 
solution was transferred to a pre-chilled electroporation cuvette (Sigma-Aldrich) with 0.1 cm gap. 
The electroporation was carried out with Bio-Rad Gene Pulser. Electroporation conditions were 200 
Ω, 25 µF and 2.00 kV.  
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Screening of transformants 
After the electroporation, the cells were cultured on selective media. 100-fold and 1000-fold 
dilutions were made of the cell suspension and 100 µl of both dilutions were plated. The undiluted 
cell suspension was centrifuged (6000 x g, 5 min) and resuspended in residual SOC (Super Optimal 
broth with Catabolite repression) solution and plated to ensure the yield of transformants. In 
addition, 100 µl of 1000-fold dilution was plated on LB agar plate without ampicillin to control 
whether the cells survived the electroporation. 100-fold dilution was made of the negative control 
after electroporation and 100 µl was plated on LB agar plates with and without ampicillin to test its 
selectiveness. 
The plates were screened for transformants, and three colonies were selected for further testing. 
The colonies were checked by colony PCR for correct insert size. The used primer pair (fwd 5’ 
GTGAGTTAGCTCACTCATTAGGC 3’, rev 5’ CCAACTTAATCGCCTTGC  3’, Metabion international AG) 
was specific to plasmid pUC19. The predicted PCR product lengths are presented in Table 5. 
Table 5. Colony PCR product sizes. 
















For strains carrying plasmids pUC19, pUC19-dfrB2_a and pUC19-dfrB2_c PCR was performed in a 
volume of 20 µl which contained 0.4 U of PhusionTM High-Fidelity DNA Polymerase (Thermo Fischer 
Scientific), dNTP Mix (0.2 mM of each) 4 µl of 5-fold PhusionTM HF Buffer (Thermo Fischer Scientific), 
0.5 µM of each of the two primers and template DNA from transformant colonies growing on LB 
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agar plates with ampicillin. The colony PCR was performed using the following program: initial 
denaturation at 98 °C for 2 min, followed by 30 cycles of 98 °C for 10 s, 59,5 °C for 30 s, and 72 °C 
for 20 s and final extension step at 72 °C for 5 min. 
For the rest of the strains, colony PCR with PhusionTM High-Fidelity DNA Polymerase did not yield 
products. Therefore the colony PCR for the strains with plasmids pUC19-ermB_a, pUC19-
ermB_b_91N, pUC19-ermB_c, pUC19-ermC_a, pUC19-ermC_b_72L, pUC19-ermC_c, pUC19-sul1_a, 
pUC19-sul1_b_72L, pUC19-sul1_c, pUC19-sul2_a, pUC19-sul2_b_75L and pUC19-sul2_c was 
performed in a volume of 25 µl which contained 1.25 U of DreamTaq DNA Polymerase (Thermo 
Fischer Scientific), dNTP Mix (0.2 mM of each) 2,5 µl of 10-fold DreamTaq Buffer (Thermo Fischer 
Scientific), 0.5 µM of each of the two primers and template DNA from transformant colonies 
growing on LB agar plates with ampicillin. The colony PCR was performed using the following 
program: initial denaturation at 95 °C for 3 min, followed by 30 cycles of 95 °C for 30 s, 59,5 °C for 
30 s, and 72 °C for 60 s and final extension step at 72 °C for 5 min.  
The colony PCR was performed in the Bio-Rad C1000 TouchTM Thermal Cycler instrument. The PCR 
products were analyzed by gel electrophoresis (E-gel iBaseTM, Invitrogen by Thermo Fischer 
Scientific) on a 2 % agarose E-gel (G401002, Invitrogen by Thermo Fischer Scientific) with GeneRuler 
1 kb DNA Ladder (SM0311, Thermo Fischer Scientific) or GeneRuler 50 bp DNA Ladder (SM0371, 
Thermo Fischer Scientific) for evaluation of the fragment sizes. 
Preparation of glycerol stocks 
The PCR-verified transformants were inoculated in 5 ml LB broth with 100 µg/ml ampicillin and 
glycerol stocks of each transformant were made after an overnight incubation at +37 °C. The stocks 
were prepared by mixing 0.5 ml of 85 % (v/v) sterile glycerol with 1 ml of bacterial cell culture in an 
Eppendorf tube. The tubes were stored at -80 °C. 
Plasmid DNA extraction and analysis of sequencing data 
In the agarose gel analysis, the PCR product sizes were observed to be approximately as expected. 
However, the products seemed slightly bigger than what was calculated. For this reason, one 
plasmid containing ermB_b_91N gene was sequenced to confirm that the transformants carry the 
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right plasmids. Plasmid DNA extraction was done for E. coli DH5α transformant carrying pUC19 
plasmid with ermB_b_91N gene. The extraction was done using Monarch® Plasmid Miniprep Kit 
(T1010S, New England BioLabs) according to manufacturer’s instructions (International.neb.com, 
2015). The DNA was eluted to 30 µl of Monarch DNA Elution Buffer. The plasmid DNA concentrations 
were determined using Qubit 4 Fluorometer (Invitrogen by Thermo Fisher Scientific). 
The extracted plasmid pUC19-ermB_b_91N was sent for two-way Sanger sequencing along with 
original pUC19-ermB_b_91N provided by Genscript, USA. The sequencing was performed, and 
sequence data was provided by FIMM Sequencing. The same primer pair that was used in colony 
PCR was used in Sanger sequencing as well. The sequencing data was analyzed with NCBI BLASTn 
(Altschul et al., 1990). 
Antibiotic susceptibility testing 
Antimicrobial gradient method was used to test the antibiotic susceptibility in form of minimal 
inhibitory concentration (MIC) values for transformant strains. The testing was performed on 
Mueller-Hinton (MH) agar with ampicillin (100 µg/ml) using Liofilchem® MIC test strips (Liofilchem, 
Italy) according to the manufacturer’s instructions. Antibiotics used in the testing were 
trimethoprim, erythromycin, and sulfamethoxazole. Transformant strains from glycerol stocks were 
precultured on LB agar with ampicillin (100 µg/ml) to get single colonies. Colonies were suspended 
in 2 ml of sterile 0.85 % (w/v) NaCl solution corresponding to 0.5 McFarland standard. The bacterial 
suspension was plated on MH agar with ampicillin (100 µg/ml) with a cotton swab to achieve a 
confluent lawn of bacteria. The MIC test strip was applied on agar surface and the plate was 
incubated for 16-20 hours in + 37 °C. After incubation, MIC value was read where the visible 
inhibition zone intersected the strip. An exception for the manufacturer’s instructions was the 
addition of ampicillin to MH agar media, which was done to avoid the loss of plasmid from the 




Figure 2. A summary of the antibiotic susceptibility testing protocol. Bacterial strain carrying 
modified ARG is illustrated in orange and wild type strain in pink. Abbreviations: LB = Luria-Bertani, 
MH = Mueller-Hinton, MIC = minimal inhibitory concentration. 
The antibiotic susceptibility testing of all strains was done twice and the MIC values of the two test 
rounds were compared. A third testing was performed if the MIC values of the two tests differed 
considerably from each other. Separately conducted antibiotic susceptibility testing experiments 
aimed to be independent from each other. For each round of testing, media was prepared 
separately. Each test round started with collecting the transformant cells were from a glycerol stock 
for the pre-culture. The same glycerol stock tube of each transformant strain was used in every test. 
E. coli DH5α (pUC19) was used as a negative control for the three tested antibiotics. E. coli DH5α 




Identification of permissive stretches 
Gaps in the MSA were observed for all the studied proteins encoded by genes ermB, ermC, ermF, 
sul1 and sul2. One or more permissive stretch within the region of the first 100 amino acids was 
identified for all the proteins (Table 6). One stretch was chosen for each protein to be the site of 
insertion. The stretches chosen for insertion were located in flexible loop regions. However, in the 
absence of more suitable alternative, for proteins encoded by sul1 and sul2, the stretch was located 
at the end of an alpha helix just before a loop. If more than one suitable stretch was identified for a 
protein, the stretch that was relatively least conserved was chosen to be the insertion site. The 
locations of the chosen permissive stretches for each protein are shown in figures of 3D protein 
structures (Fig 3.) 
Table 6. Results of permissive stretch search. The location of permissive stretch is marked as the 
first flanking amino acid of the stretch. In the column reporting lengths of permissive stretches in 
amino acids, the amino acid in parentheses indicates the location of the stretch. 
Protein No of permissive stretches 
identified within the 




stretch in amino 
acids 





















type 1 (sul1) 
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Figure 3. 3D structure models displaying the locations of the chosen permissive stretches. The first 
flanking residue of the stretch is highlighted in red. (A) 23S rRNA (adenine(2058)-N(6))-
methyltransferase (ermB) (Bhujbalrao & Anand, 2019). (B) 23S rRNA (adenine(2058)-N(6))-
methyltransferase (ermC). The 3D structure model contains a sinefungin ligand, visible in blue and 
red (Schluckebier et al., 1999). (C) Dihydropteroate synthase type 1 (sul1) (Yun et al., 2012). (D) 
Dihydropteroate synthase type 2 (sul2) (Morgan et al., 2011). The images of 3D structure models 




Transformation efficiency calculated with positive control, E. coli DH5α strain transformed with 
plasmid pUC19 without inserts, was 4.8 x 106 cfu/µg. After electroporation transformant colonies 
grew on LB agar plates with ampicillin, which indicates that plasmid pUC19 with ampicillin resistance 
gene was transformed. 
The analysis of PCR products with agarose gel electrophoresis revealed right-sized products for each 
transformant (Fig. 4). However, colony PCR was first attempted with Phusion polymerase for 
transformants presumably carrying plasmids pUC19, pUC19-dfrB2_a, pUC19-dfrB2_c, pUC19-
ermB_a and pUC19-ermB_b_91N but with this polymerase it yielded so few products (Fig. 4. A., B., 
C.), its functionality was questioned. Colony PCR with Phusion polymerase worked sufficiently only 
for the smallest inserts pUC19, pUC19-dfrB2_a and pUC19-dfrB2_c. For the rest of the 
transformants, DreamTaq polymerase was used with good results. This non-proofreading 




Figure 1. Agarose gel electrophoresis of colony PCR products. Molecular marker on gels A and B: 
GeneRuler 50 bp DNA Ladder. Molecular marker on gels C-I: GeneRuler 1 kb DNA Ladder A) 1-3: 
pUC19-dfrB2_a (no product), 4-5: pUC19-dfrB2_c (right size product), 6: pUC19-dfrB2_c (no 
product), 7: positive control pUC19 (right size product), 8: negative control. B) 1,3: pUC19-dfrB2_a 
(right size product), 2: pUC19-dfrB2_a (no product), 4: positive control pUC19 (right size product), 
5: negative control. C) 1-3: pUC19-ermB_a (no product), 4: pUC19-ermB_b_91N (right size product), 
5-6: pUC19-ermB_b_91N (no product), 8: negative control, 9: positive control pUC19 (right size 
product). D) 1-3: pUC19-ermB_a (right size product), 4: pUC19-ermB _b_91N (right size product), 5-
7: pUC19-ermB_c (right size product), 8: negative control, 9: positive control pUC19 (right size 
product). E) 1-3: pUC19-ermC_a (right size product), 4-6: pUC19-ermC_b_72L (right size product), 8: 
negative control, 9: positive control pUC19 (right size product). F) 1-3: pUC19-ermC_c (right size 
product), 4: negative control, 5: positive control pUC19 (246 bp). G) 1-3: pUC19-sul1_a (right size 
product), 4-6: pUC19-sul1_b_72L (right size product), 8: negative control, 9: positive control pUC19 
(right size product). H) 1-3: pUC19-sul1_c (right size product), 4-6: pUC19-sul2_a (right size product), 
8: negative control, 9: positive control pUC19 (right size product). I) 1-3: pUC19-sul2_b_75L (right 
size product), 4-6: pUC19-sul2_c (right size product), 8: negative control, 9: positive control pUC19 
(right size product). 
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Sequencing data analysis 
The results of sequencing data analysis of both pUC19-ermB_b_91N extracted from a transformant 
and the original plasmid delivered by Genscript confirmed the sequences to be as expected. The 
sequencing products matched with the sequence where ermB_b_91N gene is located in pUC19 
multiple cloning site. It can be concluded that the results of colony PCR are reliable even though the 
PCR product sizes seemed slightly bigger on agarose gel analysis.  
Antibiotic susceptibility of the strains 
Strains DH5α pUC19-ermB_a and DH5α pUC19-ermB_b_91N displayed equal erythromycin 
resistance to the wild type strain DH5α pUC19-ermB_c (Table 7), indicating that ermB_a and 
ermB_b_91N genes conferred resistance to erythromycin similarly as the wild type gene. Strains 
DH5α pUC19-ermC_a and DH5α pUC19-ermC_b_72L also displayed erythromycin resistance similar 
to the wild type strain DH5α pUC19-ermC_c. 
Strain DH5α pUC19-sul1_a gene displayed equal sulfamethoxazole resistance to the wild type strain 
DH5α pUC19-sul1_c, but DH5α pUC19-sul1_b_72L strain did not (Table 7). DH5α pUC19-sul1_b_72L 
strain was as sensitive to sulfamethoxazole as the negative control strain. Similarly, DH5α pUC19-
sul2_a strain displayed equal sulfamethoxazole resistance to the wild type strain DH5α pUC19-
sul2_c while DH5α pUC19-sul2_b_75L strain did not, and the resistance conferred by sul2_b_75L 
was equal to negative control. 
The results of the two antibiotic susceptibility tests were highly similar between replicates for strains 
carrying ermB, ermC, sul1 and sul2 genes and therefore testing was not repeated thrice. The exact 
MIC values for most of the strains carrying erythromycin and sulfamethoxazole resistance genes 
could not be determined as the MIC values were observed to be the equal or higher as the highest 
value on the MIC test strip scale. 
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Table 7. Minimal inhibitory concentration (MIC) values of erythromycin and sulfamethoxazole. 
MIC values from two tests for strains carrying ermB, ermC, sul1 and sul2 genes, and mean MIC values 
of the two test results. 
Strain MIC (μg/ml) of 
erythromycin 
MIC (μg/ml) of 
sulfamethoxazole 
Mean MIC value 
(μg/ml) 
 1. test 2. test 1. test 2. test  
DH5α pUC19-ermB_a ≥256 ≥256   ≥256 
DH5α pUC19-ermB_b_91N ≥256 ≥256   ≥256 
DH5α pUC19-ermB_c (WT) ≥256 ≥256   ≥256 
DH5α pUC19-ermC_a ≥256 ≥256   ≥256 
DH5α pUC19-ermC_b_72L ≥256 ≥256   ≥256 
DH5α pUC19-ermC_c (WT) ≥256 ≥256   ≥256 
DH5α pUC19-sul1_a   ≥1024 1024 ≥1024 
DH5α pUC19-sul1_b_72L   1.5 1.5 1.5 
DH5α pUC19-sul1_c (WT)   ≥1024 ≥1024 ≥1024 
DH5α pUC19-sul2_a   ≥1024 ≥1024 ≥1024 
DH5α pUC19-sul2_b_75L   3 2 2.5 
DH5α pUC19-sul2_c (WT)   ≥1024 ≥1024 ≥1024 
DH5α pUC19 (negative 
control) 32 32 1.5 1.5 
32 (erythromycin) 
1.5 (sulfamethoxazole) 
DH5α pUC19-dfrB2_a strain was more sensitive to trimethoprim than the wild type strain DH5α 
pUC19-dfrB2_c (Table 8). The resistance conferred by dfrB2_a was almost equal to negative control 
strain. The MIC values of trimethoprim for strains DH5α pUC19-dfrB2_a and DH5α pUC19-dfrB2_c 
observed in the first two tests differed between replicates and for that reason the test was repeated 
once more. The MIC values for strain DH5α pUC19-dfrB2_c differed the most as can be observed 
from standard deviation (Table 8). For strain DH5α pUC19-dfrB2_a and for the negative control 
strain the MIC values were more consistent. The MIC values of trimethoprim for strain DH5α pUC19-
dfrB2_c were the most difficult to interpret in this study due to indistinct inhibition zones (Fig. 5). 
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Table 8. Minimal inhibitory concentration (MIC) values of trimethoprim. MIC values from two tests 
for strains carrying dfrB2 gene, and mean MIC values and standard deviations of the three test 
results.  




 1. test 2. test 3. test   
DH5α pUC19-dfrB2_a 0.016 0.047 0.032 0.030 0.013 
DH5α pUC19-dfrB2_c (WT) 0.064 0.190 0.125 0.142 0.051 
DH5α pUC19  






Figure 2. Inhibition zones of strains DH5α pUC19-dfrB2_a (A), DH5α pUC19-dfrB2_c (wild type 
strain) (B) and DH5α pUC19 (negative control strain) (C). The inhibition zone of DH5α pUC19-
dfrB2_c was more indistinct than of the other two strains carrying dfrB2 gene.  
The mean MIC values of strains carrying modified ARGs were compared to mean MIC values of 
strains carrying a wild type gene (Table 7 and 8). No statistical analysis was conducted for antibiotic 
susceptibility testing results, since the goal was to find out, whether the modified genes function 
well enough compared to the wild type or not.  
In conclusion, six of the ARGs with internal modifications (ermB_a, ermB_b_91N, ermC_a, 
ermC_b_72L, sul1_a and sul2_a) conferred antibiotic resistance similarly to the wild type gene while 
three (dfrB2_a, sul1_b_72L and sul2_b_75L) did not. Two out of four (ermB_b_91N and 
ermC_b_72L) ARGs with insertions in predicted permissive stretches conferred antibiotic resistance 
equally to the wild type gene. Sul1_b_72L and sul2_b_75L did not confer antibiotic resistance. Fig. 
6 summarizes the results of antibiotic susceptibility testing by illustrating the antibiotic resistance 
levels conferred by the modified ARGs compared to the wild type. The accurate values are presented 




Figure 6. The antibiotic resistance levels conferred by modified antibiotic resistance genes 
compared to wild type gene (WT). The wild type gene is selected as the 100% level and modified 
antibiotic resistance genes and negative control are compared to it. The explanations of the types 
of genes (A and B) are in Fig. 1. 
DISCUSSION 
The aim of this study was to find out whether synthetic primer binding sites and barcode sequence 
can be introduced inside various ARGs without greatly disturbing protein function. The goal of 
antibiotic susceptibility testing was to determine whether the modified ARGs encode for functional 
proteins conferring antibiotic resistance, and whether the antibiotic resistance of the strains 
carrying the modified ARGs is similar enough to a strain carrying a wild type ARG. The functionality 
of the protein was to be maintained despite modifications to allow the ARGs to be selected by a 
corresponding antibiotic and thus to have applicable ARGs for further studies where the HGT of the 
genes will be monitored by tracing the ARGs with epicPCR. It can be concluded that six ARGs 
modified in this study are adequate for further studies since they confer sufficient antibiotic 
resistance providing advantage to the host strain and are therefore selectable with the 
corresponding antibiotic. Moreover, the epicPCR primer binding sites could be added inside these 
ARGs without impairing protein function, which allows the monitoring of ARG transfer in 
experimental conditions. The results of this study indicate that the ermB_a, ermB_b_91N, ermC_a, 
ermC_b_72L as well as sul1_a and sul2_a genes encode for functional proteins conferring antibiotic 
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resistance to erythromycin or sulfamethoxazole respectively. Due to the limited MIC test strip scale, 
it could not be determined whether the ARGs confer resistance equal to wild type gene, yet this was 
not the aim of this study. The modified ARGs are intended for an experimental evolution 
experiment, where they need to bring a significant advantage for their host. Therefore, the modified 
ARGs do not need to be equal to wild type in terms of conferring antibiotic resistance.  
Clinical and Laboratory Standards Institute (CLSI) has published MIC breakpoints of trimethoprim 
and sulfonamides for Enterobacterales, which include E. coli (Clinical and Laboratory Standards 
Institute, 2021). However, there are no MIC breakpoint values of erythromycin for Enterobacterales, 
since erythromycin is not commonly used to treat infections caused by them. Strains DH5α pUC19-
sul1_a, DH5α pUC19-sul1_c, DH5α pUC19-sul2_a and DH5α pUC19-sul2_c can be categorized as 
resistant to sulfamethoxazole as the determined MIC values of the strains exceed the MIC 
breakpoint defined by CLSI (more than 512 μg/ml), whereas strains with sul1_ b_72L and sul2_b_75L 
genes can be categorized as sensitive (determined MIC values are less than 256 μg/ml). The fact 
that the strains carrying sul1_a and sul2_a genes are resistant to sulfamethoxazole according to MIC 
breakpoints defined by CLSI supports the conclusion that the function of proteins encoded by genes 
sul1_a and sul2_a was maintained despite modifications and that the epicPCR primer binding site 
can be added inside start and stop codons for these genes. According to MIC breakpoint values 
defined by CLSI, the strains carrying modified and wild type dfrB2 would not be resistant to 
trimethoprim at all, since the MIC values determined in this study for these strains are considerably 
less than the MIC breakpoint by CLSI (more than 16 μg/ml for the category “resistant”). Both the 
modified strain DH5α pUC19-dfrB2_a as well as the wild type strain DH5α pUC19-dfrB2_c can be 
categorized as sensitive (determined MIC values are less than 8 μg/ml). Although the wild type DH5α 
pUC19-dfrB2_c strain was found not to be resistant to trimethoprim according to the MIC 
breakpoints by CLSI, clearly higher MIC values were determined for wild type DH5α pUC19-dfrB2_c 
strain than for the negative control strain or the modified DH5α pUC19-dfrB2_a strain. This allowed 
comparison of resistance levels, however with reservations since the results also differed between 
replicates. Since E. coli is a known host of dfrB2 gene and thus the gene should function properly, 
the reason why the wild type dfrB2_c conferred resistance poorly remains unclear. A point mutation 
in the gene sequence could explain the poor functionality and plasmid sequencing would provide 
more information on this. Noteworthy is also the addition of ampicillin to the plates in antibiotic 
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susceptibility testing to avoid a loss of plasmid. The additional antibiotic on a plate also containing 
a MIC test strip impregnated with another antibiotic may have caused an extra burden for bacteria 
resulting in impaired growth of strains with both dfrB2 genes.  
In this study, all the other proteins with C- and N-terminal modifications (type A genes) maintained 
their function, but DH5α pUC19-dfrB2_a strain was observed to not confer trimethoprim resistance, 
indicating a loss of function of the protein encoded by dfrB2_a. The 3D structure of protein encoded 
by dfrB2 gene was not evaluated, as the modifications were done at the C- and N-terminal ends of 
the protein and modifying the ends of the protein is safe for many proteins in terms of maintaining 
protein function. However, it is possible that a terminal region is also functionally relevant or that 
the insertion at an end interfered with protein folding.  
Based on the results of this study, sequence-based prediction of permissive sites seems to be a 
useful method, but it does not guarantee the functionality of the engineered protein. As observed 
in the antibiotic susceptibility testing, two out of four proteins with insertions in predicted 
permissive stretches maintained their function, while the other two lost their ability to confer 
antibiotic resistance. Possible reasons why the engineered proteins with insertions in predicted 
permissive stretches did not function in this study include that the region of insertion was 
functionally relevant or that the insertion interfered with protein folding thus impairing the 
function. Loop regions where the insertions were aimed are generally thought to be flexible, but 
they can also have a functional role (Papaleo et al., 2016). For example, surface-exposed loops can 
be functionally relevant due to their possibility to interact with biomolecules. Therefore, placing 
insertions on a loop structure does not guarantee that a functional region will not be interfered. 
Another possible reason for the loss of protein function is the inaccuracy in identifying the 
permissive site. The position of the permissive stretch identified by the gap in MSA is not exact as 
the used algorithm can affect the precise location of the gap (Golubchik et al., 2007). Exploring 
multiple insertion sites in a protein (Burg et al., 2016; Oesterle et al., 2017; Schlehuber & Rose, 2004) 
might give a better chance of resulting in a functional protein, although a good result can be 
achieved with one try (Sturgill et al., 2008). One predicted permissive site for insertion was tested 
for proteins of interest in this study. However, it would have been justified to try more than one 
insertion site, as well as to vary the insertion site within the identified stretch. Especially in the case 
of the protein encoded by sul1_ b_72L, placing the insertion further away from the secondary 
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structure and towards the mid of the loop structure might be worth exploring. Since neither of 
proteins encoded by genes sul1_ b_72L and sul2_b_75L was functional, it is possible that the 
insertions done in this study for these proteins were too close to the secondary structure. 
To minimize the risk of insertions in a location that would impair the function of the modified 
protein, it might be useful to utilize a protein secondary structure prediction tool such as JPred4 in 
the future. JPred4 has a secondary structure prediction accuracy of around 80% (Drozdetskiy et al., 
2015). Still, because a 3D model of the protein structure is more useful than information on 
secondary structure only, using a prediction tool might not have changed the course of this study. 
It has also been suggested that sequence-based prediction for identification of permissive sites does 
not need pre-existing data at all on functionally important regions or on protein structures (Burg et 
al., 2016). The 3D structure models of each protein were nevertheless evaluated in this study to 
place the insertions in loop regions. 
The MIC values obtained by antimicrobial gradient method in this study cannot be considered as 
exact MIC values for each strain. Yet for the purposes of this study, the antimicrobial gradient 
method is accurate enough as the observed MIC values are comparable with each other. The 
antimicrobial gradient method was chosen for this study based on its fast and easy performance 
compared to other antibiotic susceptibility testing methods such as the broth dilution method. The 
antimicrobial gradient method has limitations compared to other methods but performs generally 
well (Jorgensen & Ferraro, 2009) and it is accurate enough for clinical use (Baker et al., 1991). A 
commercial version of antimicrobial gradient method called Etest® (BioMérieux) is shown in several 
studies to be an accurate alternative for broth dilution or agar dilution methods (Baker et al., 1991; 
Di Bonaventura et al., 2002; Ming Bo Huang et al., 1992). Studies comparing Etest® and Liofilchem® 
MIC test strips used in this study have shown that Liofilchem® MIC test strips also provide acceptable 
results, but they seem to be slightly less accurate than those obtained by Etest® (Humphries et al., 
2018; Jönsson et al., 2018). The MIC test strips used in this study were from the same batch. Should 
there be deficiencies in the strips of this batch, it will show in all the results. The use of strips from 
the same batch therefore exposes the results to random deficiencies in manufacturing, but on the 
other hand the comparability of the results is maintained. Also, the antimicrobial gradient method 
is based on visual interpretation of results which may lead to dependence of the results on the 
performer of the test. Moreover, the true MIC values for strains carrying erythromycin and 
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sulfamethoxazole resistance genes could not be determined as the MIC values were observed to be 
the equal or higher as the highest value on the MIC test strip scale.  
In this study, E. coli DH5α strain used as a host and as a negative control was observed to have an 
innate resistance against erythromycin. This is consistent with previous studies analyzing clinical 
isolates where high erythromycin resistance levels in different E. coli strains have been observed 
(Kazemnia et al., 2014; Kibret & Abera 2011). Despite the natural erythromycin resistance of the 
host strain, the differences in MIC values between the negative control and the tested strains were 
clearly observable. In the future, further studies with ermB and ermC genes should be done by using 
for example erythromycin sensitive strain of Staphylococcus aureus as a host. Most methicillin 
sensitive strains of S. aureus are erythromycin sensitive (Cheng et al., 2016; Kareiviene et al., 2006) 
but S. aureus is known to express erm-mediated erythromycin resistance acquired via plasmids and 
other mobile genetic elements (Haaber et al., 2017). The ability to express erm-mediated 
erythromycin resistance acquired via plasmids suits the purposes of further studies, but when 
choosing a suitable strain, it should be checked that the strain is not already resistant. Use of S. 
aureus would also require a different plasmid since pUC19 does not replicate in it. 
The ARGs in which the modifications were done at the ends of the gene (type A), result in an epicPCR 
product longer than the desired 300 bp. In the future the applicability of these genes to epicPCR 
needs to be confirmed. Another future perspective is determining the effect of different barcode 
sequences on protein function. In this study, the same barcode sequence after the epicPCR forward 
primer binding site was used in all the genes to avoid different result in antibiotic susceptibility 
testing caused by different barcodes sequences.  
In conclusion, six ARGs modified in this study encoded for functional proteins that conferred 
antibiotic resistance while three modified ARGs did not. According to the results, the epicPCR primer 
binding sites could be added inside the genes without impairing protein function, making the ARGs 
selectable by corresponding antibiotic and amplifiable by epicPCR. The functional, antibiotic 
resistance conferring genes designed in this study can be used in further studies utilizing epicPCR, 
provided that the length of the gene sequence is not too long for epicPCR. In addition, the results 
of this study provide information on the usability of sequence-based prediction in finding permissive 
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Table S1. The accurate values of antibiotic resistance levels conferred by modified antibiotic 
resistance genes compared to wild type gene (WT). The wild type gene is selected as the 100% level 
and modified antibiotic resistance genes and negative control are compared to it.  
Strain Antibiotic resistance (%) compared to wild 
type strain 
DH5α pUC19 + dfrB2_a 20.74 % 
DH5α pUC19 + dfrB2_c (WT) 100.00 % 
DH5α pUC19 (neg) 16.64 % 
DH5α pUC19-ermB_a 100.00 % 
DH5α pUC19-ermB_b_91N 100.00 % 
DH5α pUC19-ermB_c (WT) 100.00 % 
DH5α pUC19 (neg) 12.50 % 
DH5α pUC19-ermC_a 100.00 % 
DH5α pUC19-ermC_b_72L 100.00 % 
DH5α pUC19-ermC_c (WT) 100.00 % 
DH5α pUC19 (neg) 12.50 % 
DH5α pUC19-sul1_a 100.00 % 
DH5α pUC19-sul1_b_72L 0.15 % 
DH5α pUC19-sul1_c (WT) 100.00 % 
DH5α pUC19 (neg) 0.15 % 
DH5α pUC19-sul2_a 100.00 % 
DH5α pUC19-sul2_b_75L 0.24 % 
DH5α pUC19-sul2_c (WT) 100.00 % 
DH5α pUC19 (neg) 0.15 % 
 
